These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24757226)

  • 1. Closed-loop artificial pancreas systems: engineering the algorithms.
    Doyle FJ; Huyett LM; Lee JB; Zisser HC; Dassau E
    Diabetes Care; 2014; 37(5):1191-7. PubMed ID: 24757226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices.
    Kudva YC; Carter RE; Cobelli C; Basu R; Basu A
    Diabetes Care; 2014; 37(5):1184-90. PubMed ID: 24757225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive control of artificial pancreas systems - a review.
    Turksoy K; Cinar A
    J Healthc Eng; 2014; 5(1):1-22. PubMed ID: 24691384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in closed-loop insulin delivery.
    Ware J; Hovorka R
    Metabolism; 2022 Feb; 127():154953. PubMed ID: 34890648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on Doyle et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197.
    Oliver NS; Evans ML; Hovorka R; Heller S; Johnston DG; Amiel SA; Barnard K
    Diabetes Care; 2014 Oct; 37(10):e226-7. PubMed ID: 25249686
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to comment on Doyle et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197.
    Doyle FJ; Huyett LM; Lee JB; Zisser HC; Kerr D; Dassau E
    Diabetes Care; 2014 Oct; 37(10):e228. PubMed ID: 25249687
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.
    Dadlani V; Pinsker JE; Dassau E; Kudva YC
    Curr Diab Rep; 2018 Aug; 18(10):88. PubMed ID: 30159816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial pancreas goes outpatient: a new diabetes ecosystem.
    Renard E; Cobelli C; Zisser HC; Kovatchev BP
    J Diabetes Sci Technol; 2013 Nov; 7(6):1411-5. PubMed ID: 24351167
    [No Abstract]   [Full Text] [Related]  

  • 9. Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes.
    Ramli R; Reddy M; Oliver N
    Drugs; 2019 Jul; 79(10):1089-1101. PubMed ID: 31190305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathway to artificial pancreas systems revisited: moving downstream.
    Kowalski A
    Diabetes Care; 2015 Jun; 38(6):1036-43. PubMed ID: 25998296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Artificial pancreas: where are we in 2020 ?].
    Radermecker RP
    Rev Med Suisse; 2020 Aug; 16(703):1494-1497. PubMed ID: 32852170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Technology: Monitoring, Analytics, and Optimal Control.
    Kovatchev B
    Cold Spring Harb Perspect Med; 2019 Jun; 9(6):. PubMed ID: 30126835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bio-inspired glucose controller based on pancreatic β-cell physiology.
    Herrero P; Georgiou P; Oliver N; Johnston DG; Toumazou C
    J Diabetes Sci Technol; 2012 May; 6(3):606-16. PubMed ID: 22768892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.
    Deshpande S; Pinsker JE; Zavitsanou S; Shi D; Tompot R; Church MM; Andre C; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2019 Jan; 21(1):35-43. PubMed ID: 30547670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First use of model predictive control in outpatient wearable artificial pancreas.
    Del Favero S; Bruttomesso D; Di Palma F; Lanzola G; Visentin R; Filippi A; Scotton R; Toffanin C; Messori M; Scarpellini S; Keith-Hynes P; Kovatchev BP; Devries JH; Renard E; Magni L; Avogaro A; Cobelli C;
    Diabetes Care; 2014; 37(5):1212-5. PubMed ID: 24757228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial pancreas: model predictive control design from clinical experience.
    Toffanin C; Messori M; Di Palma F; De Nicolao G; Cobelli C; Magni L
    J Diabetes Sci Technol; 2013 Nov; 7(6):1470-83. PubMed ID: 24351173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.